Data Sharing Goals for Nonprofit Funders of Clinical Trials
- PMID: 33779573
- PMCID: PMC8088851
- DOI: 10.2196/23011
Data Sharing Goals for Nonprofit Funders of Clinical Trials
Erratum in
-
Correction: Data Sharing Goals for Nonprofit Funders of Clinical Trials.J Particip Med. 2021 Jun 30;13(2):e31371. doi: 10.2196/31371. J Particip Med. 2021. PMID: 34255670 Free PMC article.
Abstract
Sharing clinical trial data can provide value to research participants and communities by accelerating the development of new knowledge and therapies as investigators merge data sets to conduct new analyses, reproduce published findings to raise standards for original research, and learn from the work of others to generate new research questions. Nonprofit funders, including disease advocacy and patient-focused organizations, play a pivotal role in the promotion and implementation of data sharing policies. Funders are uniquely positioned to promote and support a culture of data sharing by serving as trusted liaisons between potential research participants and investigators who wish to access these participants' networks for clinical trial recruitment. In short, nonprofit funders can drive policies and influence research culture. The purpose of this paper is to detail a set of aspirational goals and forward thinking, collaborative data sharing solutions for nonprofit funders to fold into existing funding policies. The goals of this paper convey the complexity of the opportunities and challenges facing nonprofit funders and the appropriate prioritization of data sharing within their organizations and may serve as a starting point for a data sharing toolkit for nonprofit funders of clinical trials to provide the clarity of mission and mechanisms to enforce the data sharing practices their communities already expect are happening.
Keywords: biomedical research; clinical trial; data sharing; patients.
©Timothy Coetzee, Mad Price Ball, Marc Boutin, Abby Bronson, David T Dexter, Rebecca A English, Patricia Furlong, Andrew D Goodman, Cynthia Grossman, Adrian F Hernandez, Jennifer E Hinners, Lynn Hudson, Annie Kennedy, Mary Jane Marchisotto, Elizabeth Myers, W Benjamin Nowell, Brian A Nosek, Todd Sherer, Carolyn Shore, Ida Sim, Luba Smolensky, Christopher Williams, Julie Wood, Sharon F Terry, Lynn Matrisian. Originally published in Journal of Participatory Medicine (http://jopm.jmir.org), 29.03.2021.
Conflict of interest statement
Conflicts of Interest: Author BAN is the Executive Director of the non-profit Center for Open Science that operates the Open Science Framework (http://osf.io/) and has a mission to increase openness, integrity, and reproducibility of research; Author IS is the Co-Founder and consultant to Vivli. Author AFH has received research funding from American Regent, Astra Zeneca, Boehringer Ingelheim, Merck, Novartis, and Verily and is also a consultant to Amgen, Astra Zeneca, Boehringer Ingelheim, Boston Scientific, Bayer, Merck, and Novartis. All other authors have no conflicts to declare.
References
-
- Institute of Medicine Sharing clinical trial data: maximizing benefits, minimizing risk. Institute of Medicine. 2015:17–18. https://www.nap.edu/catalog/18998/sharing-clinical-trial-data-maximizing... - PubMed
-
- Hudson KL, Lauer MS, Collins FS. Toward a new era of trust and transparency in clinical trials. JAMA. 2016 Oct 04;316(13):1353–4. doi: 10.1001/jama.2016.14668. http://europepmc.org/abstract/MED/27636028 - DOI - PMC - PubMed
-
- NIH NIH policy on the dissemination of NIH-funded clinical trial information. National Institutes of Health. 2016;81(183):64922–8. https://grants.nih.gov/policy/clinical-trials/reporting/understanding/ni...
-
- National Institutes of Health‚ Department of Health and Human Services Clinical trials registration and results information submission. Final rule. Fed Regist. 2016 Sep 21;81(183):64981–5157. https://www.gpo.gov/fdsys/pkg/FR-2016-09-21/pdf/2016-22129.pdf - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources